...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The journal of clinical hypertension. >Cost-Effectiveness Evaluation of a Collaborative Patient Education Hypertension Intervention in Utah
【24h】

Cost-Effectiveness Evaluation of a Collaborative Patient Education Hypertension Intervention in Utah

机译：在犹他州开展的一项合作的患者教育高血压干预措施的成本-效果评估

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

This study analyzed the cost-effectiveness of a patient hypertension education intervention that provided patient education through interactive voice response technology and distribution of automated blood pressure monitors to high-risk plan members with uncontrolled hypertension. A total of 17,318 members were identified with hypertension in an administrative database. The study sample consisted of all 534 high-risk hypertensive plan members who received blood pressure monitors. Using data on activity-based program costs and changes in hypertension control, this study modeled the intervention's cost-effectiveness relative to no intervention. The intervention was estimated to have brought hypertension under control in 151 patients during the study year. Across all 534 participants in 1year, 0.3 events (acute myocardial infarction, stroke, congestive heart failure, and renal failure) were avoided and 2.77 life-years were gained (LYG). The incremental cost-effectiveness ratio (ICER) for the intervention compared with no intervention was $767 per person brought under control or $41,927 per LYG. If the gains in hypertension control from 1year's investment were assumed to last 10years, the 10-year ICER relative to no intervention was $1857 per LYG. The intervention is a cost-effective strategy to address hypertension and can serve as a model for future innovations.
机译：这项研究分析了患者高血压教育干预措施的成本效益，该干预措施是通过交互式语音响应技术为患者提供教育的，并为血压不受控制的高危计划成员分配了自动血压监测仪。在一个管理数据库中，总共确定了17,318名患有高血压的成员。该研究样本包括所有534位接受血压监测仪的高风险高血压计划成员。使用基于活动的计划成本和高血压控制变化的数据，本研究对干预的成本效益进行了建模，相对于无干预而言。在该研究年度中，据估计该干预措施使151名患者的高血压得到控制。在1年的所有534位参与者中，避免了0.3次事件（急性心肌梗塞，中风，充血性心力衰竭和肾衰竭），并且获得了2.77个生命年（LYG）。与没有干预措施相比，干预措施的成本效益比（ICER）增加为每人767美元或每LYG 41,927美元。如果假设从1年的投资中获得的高血压控制收益可以持续10年，则相对于无干预措施的10年ICER为每LYG 1857美元。干预是解决高血压的一种经济有效的策略，可以作为未来创新的典范。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号